Kidney anemia pill for kids pulled before starting
NCT ID NCT05082571
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study planned to test a daily pill called vadadustat for anemia in children with chronic kidney disease. It aimed to see if the pill could safely replace standard injections. However, the trial was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vadadustat (a pill to boost red blood cell production)
- What this could lead to
- If it had worked, this could have offered a daily pill to manage anemia in children with kidney disease, possibly replacing injections.
- What could go wrong
- The trial was withdrawn before any participants enrolled, so no data exist. Even if run, it was an early-phase study with unknown safety and efficacy in children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA OF CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Hackensack, New Jersey, 07601, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill tailored to inflammation boost red blood cells in kidney disease?
- New anemia drug for dialysis patients enters final testing phase
- Could a pill replace needles for anemia in dialysis?
- New hope for kidney patients: experimental anemia drug shows promise
- Kidney anemia pill study for kids pulled before it started
- New anemia pill for dialysis patients tested against standard shots